Correlation Between Anixa Biosciences and INmune Bio

Can any of the company-specific risk be diversified away by investing in both Anixa Biosciences and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anixa Biosciences and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anixa Biosciences and INmune Bio, you can compare the effects of market volatilities on Anixa Biosciences and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anixa Biosciences with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anixa Biosciences and INmune Bio.

Diversification Opportunities for Anixa Biosciences and INmune Bio

0.55

Correlation Coefficient

Anixa Biosciences  INmune Bio

Very weak diversification

The 3 months correlation between Anixa and INmune is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Anixa Biosciences and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Anixa Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anixa Biosciences are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Anixa Biosciences i.e., Anixa Biosciences and INmune Bio go up and down completely randomly.

Pair Corralation between Anixa Biosciences and INmune Bio

Given the investment horizon of 90 days Anixa Biosciences is expected to generate 0.98 times more return on investment than INmune Bio. However, Anixa Biosciences is 1.02 times less risky than INmune Bio. It trades about 0.01 of its potential returns per unit of risk. INmune Bio is currently generating about -0.02 per unit of risk. If you would invest  323.00  in Anixa Biosciences on September 3, 2024 and sell it today you would lose (9.00) from holding Anixa Biosciences or give up 2.79% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Anixa Biosciences  vs.  INmune Bio

Anixa Biosciences

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Anixa Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, Anixa Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

INmune Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days INmune Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Anixa Biosciences and INmune Bio

The main advantage of trading using opposite Anixa Biosciences and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anixa Biosciences position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.

The idea behind Anixa Biosciences and INmune Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.